Dr. Korn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3501 N Scottsdale Rd
Ste 130
Scottsdale, AZ 85251Phone+1 480-425-5000Fax+1 480-945-6548
Education & Training
University of Pennsylvania Health SystemFellowship, Nuclear Radiology, 1991 - 1996
Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1990 - 1991
Stanford University School of MedicineClass of 1990
Certifications & Licensure
AZ State Medical License 1996 - 2025
WA State Medical License Active through 2013
PA State Medical License 1991 - 2002- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 3 citationsAxicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.Frederick L Locke, Olalekan O Oluwole, John Kuruvilla, Catherine Thieblemont, Franck Morschhauser
Blood. 2024-06-13 - 2 citationsMagnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.Andrés M Arias-Lorza, James R Costello, Sunil R Hingorani, Daniel D Von Hoff, Ronald L Korn
Scientific Reports. 2024-05-21 - 28 citationsThree-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, Narendranath Epperla, Matthew Ulrickson
Blood. 2024-02-08
Journal Articles
- E6201, an Intravenous MEK1 Inhibitor, Achieves an Exceptional Response in BRAF V600E-Mutated Metastatic Malignant Melanoma with Brain MetastasesMitesh J Borad, Raoul Tibes, Michael S Gordon, Ronald L Korn, Investigational New Drugs
Press Mentions
Breakthrough Radiomic Technology Patent Issued to Imaging EndpointsJanuary 13th, 2020
Expert Radiologist Ronald L. Korn, MD, to Be Recognized as a 2016 Top Doctor in Scottsdale, ArizonaDecember 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
